BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27435395)

  • 1. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
    Samaeekia R; Adorno-Cruz V; Bockhorn J; Chang YF; Huang S; Prat A; Ha N; Kibria G; Huo D; Zheng H; Dalton R; Wang Y; Moskalenko GY; Liu H
    Clin Cancer Res; 2017 Feb; 23(4):1091-1103. PubMed ID: 27435395
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.
    Bockhorn J; Yee K; Chang YF; Prat A; Huo D; Nwachukwu C; Dalton R; Huang S; Swanson KE; Perou CM; Olopade OI; Clarke MF; Greene GL; Liu H
    Breast Cancer Res Treat; 2013 Jan; 137(2):373-82. PubMed ID: 23224145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.
    Bockhorn J; Dalton R; Nwachukwu C; Huang S; Prat A; Yee K; Chang YF; Huo D; Wen Y; Swanson KE; Qiu T; Lu J; Park SY; Dolan ME; Perou CM; Olopade OI; Clarke MF; Greene GL; Liu H
    Nat Commun; 2013; 4():1393. PubMed ID: 23340433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling.
    Asparuhova MB; Secondini C; Rüegg C; Chiquet-Ehrismann R
    Mol Oncol; 2015 Oct; 9(8):1510-27. PubMed ID: 25999144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
    Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
    Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
    Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
    J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
    Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
    Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.
    Lin Y; Liu AY; Fan C; Zheng H; Li Y; Zhang C; Wu S; Yu D; Huang Z; Liu F; Luo Q; Yang CJ; Ouyang G
    Sci Rep; 2015 Apr; 5():9995. PubMed ID: 25919570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
    Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
    J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
    Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.
    Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
    Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
    Hanieh H
    Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
    Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.
    Lu YC; Cheng AJ; Lee LY; You GR; Li YL; Chen HY; Chang JT
    Sci Rep; 2017 May; 7(1):2042. PubMed ID: 28515423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.